LEGOO Temporary Endovascular Occluder
PMA P110003
LEGOO Temporary Endovascular Occluder is a Class III device made by Genzyme Corp., approved under FDA PMA P110003 on 28 Sep 2011, withdrawn as of 6 Oct 2026. 18 FDA recalls are linked to it.
Withdrawn
PMA, withdrawn
Ended
Withdrawn 28 Sep 2011
FDA recalls
None ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPWD | NumberP110003 | Date28 Sep 2011 | StatusWithdrawn |
Official records
- FDA PMA database P110003
Recalls
-
- Terminated Z-2153-2013
- Terminated Z-2145-2013
- Terminated Z-2143-2013
- Terminated Z-2155-2013
- Terminated Z-2141-2013
- Terminated Z-2140-2013
- Terminated Z-2139-2013
- Terminated Z-2144-2013
- Terminated Z-2142-2013
- Terminated Z-2152-2013
- Terminated Z-2146-2013
- Terminated Z-2148-2013
- Terminated Z-2147-2013
- Terminated Z-2149-2013
- Terminated Z-2154-2013
- Terminated Z-2151-2013
- Terminated Z-2156-2013
- Terminated Z-2150-2013
Product contains particulates (fibers)
Timeline
- Recall initiated FDA recalls Z-2142-2013
- Recall initiated FDA recalls Z-2152-2013
- Recall initiated FDA recalls Z-2146-2013
- Recall initiated FDA recalls Z-2148-2013
- Recall initiated FDA recalls Z-2147-2013
- Recall initiated FDA recalls Z-2149-2013
- Recall initiated FDA recalls Z-2154-2013
- Recall initiated FDA recalls Z-2151-2013
- Recall initiated FDA recalls Z-2156-2013
- Recall initiated FDA recalls Z-2150-2013
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Withdrawn
Specification
- Full name
- Legoo
- Generic name
- Occluder, internal vessel, temporary
- PMA number
- FDA product code
- OBC
- Device class
- Class III
- Advisory committee
- Cardiovascular
- FDA decision
- APWD Approval withdrawn